Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
about
Non-alcoholic fatty liver disease: what the clinician needs to know.A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDExtracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver DiseaseLiver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesRole of diet on non-alcoholic fatty liver disease: An updated narrative reviewAstaxanthin as a Potential Protector of Liver Function: A ReviewCo-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review articleNoninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na/K-ATPase/ROS Amplification in C57Bl6 and ApoE Knockout Mice Fed a Western Diet.Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesisElevated levels of alanine transaminase and triglycerides within normal limits are associated with fatty liverFactors associated with significant liver fibrosis assessed using transient elastography in general population.The role of interleukin-6 and interleukin-8 gene polymorphisms in non-alcoholic steatohepatitis.Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography.Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort.Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis.Age-dependent development of liver fibrosis in Glmp (gt/gt) mice.Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.Childhood Adiposity and Nonalcoholic Fatty Liver Disease in Adulthood.Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention.Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.Correlation of serum alanine aminotransferase and aspartate aminotransferase with coronary heart disease.Functional Liver Recovery After Bariatric Surgery--a Prospective Cohort Study with the LiMAx Test.New Era for Usage of Serum Liver Enzymes as A Promising Horizon for the Prediction of Non-Alcoholic Fatty Liver Disease.Recurrent purpura due to alcohol-related Schamberg's disease and its association with serum immunoglobulins: a longitudinal observation of a heavy drinker.Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease.The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.Non-alcoholic Fatty Liver Disease: A Clinical Update.Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital.Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.Guidelines on the management of abnormal liver blood tests.The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.
P2860
Q24563068-02323199-0251-4ACC-93BB-266F90D2EA57Q26752487-03166C2F-D333-4167-94E0-2C766B71C280Q26764843-A12C55C7-8246-4236-94F6-485E5A27B451Q26780252-97C3A12F-17C4-48C0-9C3A-9B4DAC42D7D2Q26828855-A7166849-FBEF-4D29-9F5B-168297D666DFQ27000333-E70B7102-AACE-4FB3-A331-9C60BB08C82FQ28070358-A449E4A0-F3A4-4EB2-A291-3EBC40B06163Q28076892-2A08D86A-C57F-488E-A2D6-BF5EFCE660B8Q28082686-557FE4AB-17E5-42FA-9E65-DFD2EB8DF4A1Q30241387-62960BE4-5819-4E8A-9497-238C87BFCBF3Q30252383-976C7887-1950-4CDB-B8D2-2C0A114A6990Q33671222-CD2C376D-4365-4E10-90CB-3651A20B543FQ33886918-582E7F1D-BADF-410D-8053-35DB15159114Q33962221-4F2BC1CF-AF07-4790-A038-4870FCE06DDBQ35012048-D9025E41-9AFA-4AB4-A0BF-B8E62B107738Q35085713-1227B4EB-A1A4-4EEA-A399-A20A05503369Q35573240-5DCBF467-5734-4A5D-9C80-CBF5DC2E164EQ35948791-D88DE707-02A0-4788-B034-25EE237767FAQ36267994-580C64C9-C83D-415E-ABAC-027431D52417Q36751392-474A050D-9B6F-4B23-AAE4-02543F94155DQ36855750-0A9B5AE7-14E5-48E4-B114-74E01BA2AB65Q38675714-FC98EAB5-8785-45B1-BCEE-4869182563DFQ38868400-C2D10F75-B39E-470F-A930-2FBA9BEAB11FQ38911612-8EA2CE7C-C273-4244-A0DE-5ECA9381B1ADQ39630894-4EEE6F58-469D-444D-A7AF-E6A233C783F3Q40195442-CDD0C85F-D482-4FDD-9F18-F2D586026DBDQ40471167-4E49F664-6B8B-43F4-A9AE-1F2704CCF2E1Q40513071-669851D5-A9E7-4008-9DBB-311F8A2D7025Q41048738-A0D6FF02-A466-47F5-8C68-8942981357F9Q41078463-4A982908-CA63-42B6-9F97-51E150E2F38AQ41231178-180EABA6-65DC-4D87-9CC2-09A849E17D43Q41635147-158AF298-CB6B-470A-9E0C-DA20F13A3CE3Q41706840-0288101F-87B3-47AB-8220-CF6F05F305D7Q43786135-91C964E0-E202-44E0-918F-ED8B2FD4A164Q47100244-8B57D186-8027-4D70-A635-5ADC737180ECQ47228561-363ED5BB-A605-4287-990F-824BF22247D5Q47430306-A337FBEE-2CED-43D9-8341-2CFB5166FC5CQ47613489-D27C4A64-2E2F-4FE0-B296-8F08637DE19EQ47884913-A4FE246C-E465-49AE-9657-CC6269502BF1Q49193626-6A1C9C4A-168C-496D-AE54-B50E1C05B4FA
P2860
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Predictive value of ALT levels ...... c fatty liver disease (NAFLD).
@en
Predictive value of ALT levels for non-alcoholic steatohepatitis
@nl
type
label
Predictive value of ALT levels ...... c fatty liver disease (NAFLD).
@en
Predictive value of ALT levels for non-alcoholic steatohepatitis
@nl
prefLabel
Predictive value of ALT levels ...... c fatty liver disease (NAFLD).
@en
Predictive value of ALT levels for non-alcoholic steatohepatitis
@nl
P2093
P2860
P356
P1433
P1476
Predictive value of ALT levels ...... c fatty liver disease (NAFLD).
@en
P2093
Donald Jensen
Siddharth Verma
Smruti R Mohanty
P2860
P304
P356
10.1111/LIV.12226
P577
2013-06-13T00:00:00Z